Sign up United Kingdom
Pfizer (:PFE)

Pfizer (:PFE)

Share Price
$ 43.12
-0.66 (-1.51 %)
Market Cap
$252,774.16 m
Proactive Investors - Run By Investors For Investors


Pfizer are committed to applying science and our global resources to improve health and wellbeing at every stage of life. They strive to provide access to clinically effective and affordable medicines and related healthcare services to the people who need them.

Market: NYSE:PFE
52-week High/Low: $45.81 / $33.20
Sector: Pharma & Biotech
Market Cap: $252,774.00M

Interactive graph

col 3
col 4
col 5
col 6

Pfizer Timeline

Pharmaceuticals behemoth Pfizer Inc shares remained resilient after broker Jefferies trimmed its price target on the pharmaceutical giant's stock to $42 from $40, as Pfizer leadership prepares to decide whether to separate its global established business from the rest of the company
Not for the first time has the ambitious and acquisitive pharmaceutical behemoth Pfizer has been upset at the merger altar, but with its Allergan deal under threat, the company may well step back and assess shareholder value

© Proactive Investors 2018

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use